FATEFate Therapeutics, Inc.
2.330USD-12.08%Mkt Cap: 279.18M $P/E: —3d ago
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen r…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap279.18M $
Enterprise Value215.47M $
Revenue (TTM)6.49M $
Gross Profit-77.93M $
Net Income (TTM)-136.31M $
Revenue/Share0.0540 USD
Last Price2.330 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees161
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS31189P1021
Valuation
P/E (Trailing)—
P/E (Forward)-2.53
PEG—
EV/EBITDA-1.79
EV/Revenue33.19
P/S45.23
P/B1.86
EPS (TTM)-0.96
EPS (Forward)-0.97
52W Range
0.930061% of range3.230
52W High3.230 USD
52W Low0.9300 USD
Profitability
Gross Margin0.00%
Oper. Margin-1495.39%
EBITDA Margin0.00%
Profit Margin-2051.08%
ROE-65.79%
ROA-42.74%
Growth
Revenue Growth9.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-106.08M $
CapEx (TTM)5.95M $
FCF Margin-749.64%
FCF Yield-17.43%
Net Debt-78.09M $
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity0.38
Current Ratio4.85
Quick Ratio4.75
Book Value/Sh1.315 USD
Cash/Share1.283 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.744 USD
Upside (mean)+146.5%
Target Range2.200 USD – 8.000 USD
$2.200+146.5% to mean$8.000
# Analysts9
Ownership
Shares Out.119.82M
Float104.81M
Insiders1.07%
Institutions68.93%
Short Interest
Short Ratio2.7d
Short % Float7.47%
Short % Out.6.59%
Shares Short7.68M
Short (prev mo.)7.43M
Technical
SMA 502.534 (-8.0%)
SMA 2001.649 (+41.3%)
Beta2.55
S&P 52W Chg18.16%
Avg Vol (30d)2.28M
Avg Vol (10d)1.97M
Technical Indicators
RSI (14)40.9
MACD-0.0007
MACD Signal0.0220
MACD Hist.-0.0227
BB Upper2.826 USD
BB Middle2.543 USD
BB Lower2.261 USD
BB Width22.24%
ATR (14)0.2049 USD
Vol Ratio (20d)0.88x